Skip to content

Pretreatment prognostic factors for predict survival outcome in advanced non small cell lung cancer with first line treatment in Thailand. A retrospective cohort study

Pretreatment prognostic factors for predict survival outcome in advanced non small cell lung cancer with first line treatment in Thailand. A retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20161219003
Enrollment
Unknown
Registered
2016-12-19
Start date
2015-01-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focus on Pretreatment Factors that possible effect to survival Pretreatment factors&#44

Interventions

Advanced stage Non Small Cell Lung cancer patients
Other
Advanced stage Non Small Cell Lung cancer patients

Sponsors

Faculty of medicine,Chulalongkorn university
Lead Sponsor
Police General Hospital
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Non small cell lung cancer who the oncologists consider receive treatment 2. Age ≥ 18 years 3. Definite diagnosis of NSCLC by histology, or cytology 4. Complete of laboratory investigation within1 week before starting chemotherapy 5. Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2

Exclusion criteria

Exclusion criteria: Previous treatment of chemotherapy or chemo radiotherapy 2. Patients who have NSCLC as a new second primary cancer. 3. Patients who have history of any infection within 2 weeks before chemotherapy 4. Patients who have history of chronic liver disease,or autoimmune disease 9

Design outcomes

Primary

MeasureTime frame
event 3 years retrospective data survival

Secondary

MeasureTime frame
Depression symptom score baseline, week4 and week12 HRDS score/ clinician rated,urine 8-isoprostane baseline, week4 and week12 EIA kit/ mg,urine melatonin baseline, week4 and week12 EIA kit/ mg,adverse event baseline, week4 and week12 Adverse effects symptom check list /self-rated .

Countries

Thailand

Contacts

Public Contactsureerat jaruhathai

Police Geneal Hospital

sjaruhathai@gmail.com+66818066280

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026